LINC02818

Across TCGA pan-cancer cohorts, LINC02818 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated LINC02818 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher LINC02818 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02818 expression acts as an unfavorable survival marker, although some lineages such as SKCM and UCS show a favorable association.

CESC, ACC, and MESO are the cancer types where LINC02818 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	DFS	Median	All	0.658	0.813	<.001	78	view →
ACC	DFS	Tertile	II,III,IV	0.387	0.812	<.001	72	view →
MESO	DFS	Tertile	All	0.272	0.519	.005	50	view →
SKCM	OS	Tertile	II,III,IV	0.379	0.234	.001	43	view →
LGG	DFS	Median	All	0.326	0.477	<.001	34	view →
UCS	OS	Tertile	II,III,IV	0.844	0.444	.006	30	view →
BRCA	OS	Median	III,IV	0.404	0.674	.002	24	view →
DLBC	DFS	Tertile	All	0.624	0.945	.007	24	view →
STAD	DFS	Median	II,III,IV	0.362	0.638	.010	23	view →
BLCA	OS	Quartile	II,III,IV	0.608	0.766	.007	18	view →
HNSC	OS	Tertile	All	0.716	0.813	.008	17	view →
THCA	DFS	Median	IV	0.492	1.000	.009	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

LINC02818–CESC (DFS)

Open the CESC breakdown →